Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for purifying acipimox

A technology of acipimox and purification method, which is applied in the direction of organic chemistry, can solve the problem of low purity of acipimox, and achieve the effects of cost saving, high purification yield and simple operation method

Pending Publication Date: 2022-01-14
LUNAN PHARMA GROUP CORPORATION
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The impurities in acipimox mainly include: excessive oxidation, isomeric position oxidation, decarboxylation impurities, etc. make acipimox not high in purity
However, there are few reports on the refining methods of acipimox in the prior art, and most of them are refined by heating and dissolving, decolorizing and recrystallizing. Therefore, it is urgent to find a method with simple operation and good refining effect. question

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for purifying acipimox
  • Method for purifying acipimox
  • Method for purifying acipimox

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] 1. Preparation of crude acipimox:

[0040] Add 10g of sodium tungstate to 200mL of purified water under stirring, add 110g of 30% hydrogen peroxide after the solid is dissolved, slowly add sulfuric acid dropwise to adjust the pH to 1~2 after the addition is complete, and after stirring for 1 hour, add 5-methylpyrazine- 70g of 2-carboxylic acid, heated to 60-70°C, reacted for 20h, cooled to 0-5°C, continued to stir for 1-2h, and filtered with suction to obtain a pale yellow solid, which was dried to obtain 54.7g of crude acipimox with a purity of 94.813 %.

[0041] 2. Purification of Crude Acipimus

[0042] At room temperature, 20 g (0.13 mol) of crude acipimox was added into 400 mL of purified water under stirring, and 10% sodium hydroxide solution was slowly added dropwise to the system to adjust the pH to 9-10. At this time, the solids were completely dissolved, and 21.65 g (0.195 mol) of anhydrous calcium chloride was added, and the mixture was stirred for 30 minut...

Embodiment 2

[0044] 1. Preparation of acipimox crude product: as in Example 1

[0045] 2. Purification of Crude Acipimus

[0046]At room temperature, 20 g (0.13 mol) of crude acipimox was added into 400 mL of purified water under stirring, and 10% sodium hydroxide solution was slowly added dropwise to the system to adjust the pH to 9-10. At this time, the solids were completely dissolved, and 14.43 g (0.13 mol) of anhydrous calcium chloride was added, and the mixture was stirred for 30 minutes, cooled to 0-5° C., and a large amount of solids gradually precipitated. Stirring was continued for 2h, and a light yellow solid was obtained by suction filtration. Add all the solids into 106 g of 20% sodium carbonate aqueous solution (sodium carbonate, 0.20 mol) in mass fraction, raise the temperature to 60°C, stir for 2 hours, cool in an ice-water bath to 0-5°C, and filter with suction, and adjust the pH of the filtrate to 1 with concentrated hydrochloric acid. ~2, stirred at 0~5°C for 2 hours, ...

Embodiment 3

[0048] 1. Preparation of acipimox crude product: as in Example 1

[0049] 2. Purification of Crude Acipimus

[0050] At room temperature, 20 g (0.13 mol) of crude acipimox was added into 400 mL of purified water under stirring, and 10% sodium hydroxide solution was slowly added dropwise to the system to adjust the pH to 9-10. At this time, the solids were completely dissolved, and 28.86g (0.26mol) of anhydrous calcium chloride was added, and the mixture was stirred for 1 hour, cooled to 0-5°C, and a large amount of solids gradually precipitated. Stirring was continued for 2h, and a light yellow solid was obtained by suction filtration. Add all the solids into 106 g of 20% sodium carbonate aqueous solution (sodium carbonate, 0.20 mol) in mass fraction, raise the temperature to 55°C, stir for 2 hours, cool in an ice-water bath to 0-5°C, and filter with suction, and adjust the pH of the filtrate to 1 with concentrated hydrochloric acid. ~2, stirred at 0~5°C for 2 hours, filtere...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
crystallization temperatureaaaaaaaaaa
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicines, and provides a method for purifying acipimox, which comprises the following steps of: using water as a solvent of an acipimox crude product, dropwise adding alkali liquor to completely dissolve solids, adding a complexing agent to precipitate the solids, decomplexing the obtained complex, adjusting acid, and conducting cooling and crystallizing to obtain the high-purity acipimox. The used refining solvent is water, so that the use of an organic solvent and activated carbon is avoided, the problem that the solvent residue exceeds the standard is solved, the method is environment-friendly, and the cost is saved. The method is high in purification yield, simple in operation method and suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a method for purifying acipimox. Background technique [0002] Acipimox (Acipimox) is a long-acting lipid-lowering drug, which was first applied for marketing in Italy by Pharmacia in 1985. Then, relying on its high safety and remarkable curative effect, it has been listed in many countries and regions such as Germany, Chile, Switzerland, Hong Kong, China, etc., as a kind of niacin derivative, which inhibits the release of free fatty acids from adipose tissue, resulting in the release of free fatty acids. Entering the liver is reduced, TG synthesis is blocked, and the VLDL-C formed by apolipoprotein Bl00 is correspondingly reduced, and LDL-C is also reduced, which can activate lipoprotein esterase, reduce VLDL-C and LDL-C, and reduce TG and total TC , Improve HDL levels. It is mainly used for the treatment of hypertriglyceridemia (type Ⅳ), hypercholesterolemia type...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D241/24
CPCC07D241/24
Inventor 朱安国崔维琛
Owner LUNAN PHARMA GROUP CORPORATION